Injectable propofol formulations
OwnerGene Komerinventor
Life of this patent
Estimating the term…
Abstract
The invention provides injectable formulations of propofol using N-methylpyrrolidone or 2-pyrrolidone as a solvent. Formulations of the invention are useful in all medical and veterinary indications when propofol is presently used. In addition, combinations of propofol and an appropriate toxin are useful for fast-acting, humane, veterinary euthanasia injectable compositions. N-methylpyrrolidone-propylene glycol formulations are inherently bacteriostatic, thereby eliminating one of the problems associated with currently available formulations.
Claims19
An injectable anesthetic formulation comprising propofol and N-methyl pyrrolidone, or 2-pyrrolidone, or a mixture thereof.
A formulation for veterinary euthanasia comprising propofol, a skeletal muscle relaxant and N-methyl pyrrolidone, 2-pyrrolidone or a mixture thereof.
Dependencies are inferred from the claim text.